species, including man, under laboratory conditions (Rapp & Reed 1976) . Transformed hamster cells develop into malignant tumours if reimplanted into newborn hamsters, but immunization by HSV does not confer protection against such tumours. Indeed, in immunized hamsters the primary tumour grows more rapidly than in non-immunized animals (Thiry et al. 1975 ) and metastasis to the lungs occurs more frequently (Duff et al. 1973) . The reasons are unknown, but serum blocking factors might be involved.
Conclusions
The immune response may provide some protection against the growth of malignant tumours. Manipulation of the response by immunotherapy may be clinically beneficial to patients with cancer, but laboratory studies must be employed to elucidate the mechanisms involved. Immunization against malignant lymphomas is well established in animals, and might be effective in prevention of Burkitt's lymphoma in man. Herpes simplex virus has been associated with squamous cell carcinoma in man but further studies will be required to determine whether malignant transformation in vivo can be a consequence of HSV infection. Immunization of animals against HSV-associated tumours has enhanced tumour growth, and laboratory studies of the mechanisms involved will be necessary before a vaccine against HSV-associated tumours can be developed. The management of oral cancer is still the subject of debate because the two traditional methods of treatment, surgery and radiotherapy, both have their champions. The first serious attempts to treat mouth cancer were surgical but with the limited facilities available morbidity and mortality were considerable. The advent of radiation therapy at the turn of the century offered hope of a safer and less destructive means of treatment.
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The value of radiotherapy is now well established but over the last few decades its limitations have also become clear. At the same time surgical science and techniques have developed so that major excisions can be performed with relative safety and, equally important, repaired without delay. The problem is to maintain a balanced view as the pendulum swings. This can be achieved only if patients are treated by a multidisciplinary team whose members are aware both of the possibilities and the limitations of their own and each others' techniques.
Squamous carcinoma of the oral cavity kills when we fail to control either the primary tumour or its cervical lymph node metastasesor sometimes both. Death from metastases below the clavicle is relatively infrequent though its incidence has risen with increasing success in local control. Effective management of the primary site and cervical nodes is therefore of paramount importance. The risk of cervical node involvement in oral cancer is high so that the treatment of the primary tumour and the nodes must be planned in an integral manner, whichever method or combination of methods is selected. There has in the past been a tendency to separate the management of the primary tumour and the lymph nodes in the belief that whereas the primary growth was -often radiosensitive, its cervical metastases were not. The development of supervoltage sources which enable radical radiation doses to be given safely to the cervical node areas has dispelled this dogma and there is now ample evidence that squamous cancer responds alike, poorly or well, whether within the mouth or in the cervical nodes. To generalize on the subject of oral cancer, surgery offers the better chance in some situations, while in others the reverse holds true. In many instances the chances of success are about equal for radiation or surgery. For yet others there is a strong case to be made for the planned combination of radiation, surgery and sometimes cytotoxic therapy. Surgery is clearly necessary after radiation failure or where a second primary tumour arises close to a previously irradiated field. Surgery is also indicated where there is more than minimal involvement of bone and also for the uncommon verrucous carcinoma. Surgery is preferred for superficial carcinoma arising in a leukoplakic or erythroplastic mucosa, and for deeply infiltrating carcinomas of the buccal mucosa. Radiotherapy by external beam is indicated for certain poorly differentiated carcinomas arising in the oropharyngeal region. Within the oral cavity proper, interstitial irradiation remains a most valuable technique in the treatment of small or moderate sized lesions of the tongue or floor of mouth provided they are clear of the mandible. The interstitial method carries the advantage of a high local cure rate with conservation of the normal anatomy, short treatment time, moderate post-irradiation effects with minimal scarring and good function, together with the early recognition of primarily radioresistant lesions which can be submitted to salvage surgery without delay. Furthermore the sparing of normal surrounding tissue permits subsequent local surgery with good healing, even after late recurrence.
Assuming control at the primary site, when the cervical lymph nodes are palpable and operable the mainstay of management remains radical neck dissection. Adjunctive radiotherapy given preor post-operatively reduces the local recurrence rate in the neck. Where the nodes cannot be palpated the choice has lain between prophylactic (elective) neck dissection or careful, frequent follow up, the operation being performed only if and when glands appear. The results are about equal and the arguments for each side have never been satisfactorily resolved. This controversy may now be superseded by the policy of prophylactic supervoltage irradiation to the cervical node areas which has been shown to be highly effective in sterilizing subclinical cancer in this site and will largely prevent the development of clinical disease provided the primary remains controlled.
With increasing size of the primary lesion the incidence of cervical metastasis increases and the prospects of cure fall off rapidly whether treatment is by external beam radiation or major resection. Radiation can yield remarkable cures both in the primary site and in the adjacent lymphatic areas which are commonly encompassed within the treatment field. The results of radiotherapy are unpredictable but in the older and physically or emotionally frailer patient it is reasonable to irradiate initially as for cure, reserving surgery for those in whom the cancer persists or recurs. Modern reconstructive methods using well-vascularized regional flaps have largely removed the anxieties relating to wound breakdown, fistula formation, carotid hemorrhage, &c., which were so much feared in the past. For the younger and fitter patient, however, who demands every chance of survival, the present indications are that the planned combination of preoperative radiotherapy followed by surgery should be advised. The investigation of this combined approach is still in its early stages and its advantages have been neither fully defined nor proved. Cytotoxic therapy must also be considered in the discussion of planned combination treatment. Cytotoxic drugs were first shown to be effective in squamous cell cancer of the head and neck when given via the intra-arterial route. This approach has been abandoned' in most institutions because the field of treatment is restricted by. the local vascular anatomy and there are difficulties and complications attendant on the presence of a prolonged indwelling intra-arterial catheter. Interest has now turned to systemic chemotherapy which, in combinations containing agents such as methotrexate, bleomycin, vincristine, hydroxyurea, &c., can induce considerable tumour response with reasonable regularity'and acceptable toxicity. Many important questions in the field of combined management remain unanswered. Is radiation best given preor post-operatively and in what dosage? Should cytotoxic therapy provide the opening attack or accompany preoperative irradiation ? Is there a place for prolonged post-radiation/surgical chemotherapy as appears so promising in breast cancer? Will preoperative radiation/chemotherapy permit less radical surgical resection? The challenge of oral cancer owes much to the fact that treatment is multifaceted and the individual facets are continually undergoing change. The above broad sketch of strategy attempts to summarize some of the policies practised today. These policies constantly need to be modified as evidence from new work is gathered and assessed.
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